Redundant function of cmaA2 and mmaA2 in Mycobacterium tuberculosis cis cyclopropanation of oxygenated mycolates

Journal of Bacteriology

Volumn 192, Issue 14, 2010, Pages 3661-3668

  Barkan, Daniel ^a   Rao, Vivek ^a   Sukenick, George D ^a   Glickman, Michael S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CMAA1 ENZYME; CMAA2 ENZYME; METHOXYMYCOLIC ACID; METHYLTRANSFERASE; MMAA1 ENZYME; MMAA2 ENZYME; MYCOLIC ACID; OXOMYCOLIC ACID; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; CHEMICAL MODIFICATION; CYCLOPROPANATION; GENE MUTATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OXYGENATION; PRIORITY JOURNAL;

BACTERIAL PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; METHYLTRANSFERASES; MYCOBACTERIUM TUBERCULOSIS; MYCOLIC ACIDS; OXYGEN;

MYCOBACTERIUM TUBERCULOSIS;

EID: 77954406755     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.00312-10     Document Type: Article

References (28)

1. Alahari, A., L. Alibaud, X. Trivelli, R. Gupta, G. Lamichhane, R. C. Reynolds, W. R. Bishai, Y. Guerardel, and L. Kremer. 2009. Mycolic acid methyltransferase, MmaA4, is necessary for thiacetazone susceptibility in Mycobacterium tuberculosis. Mol. Microbiol. 71:1263-1277.
2. Barkan, D., Z. Liu, J. C. Sacchettini, and M. S. Glickman. 2009. Mycolic acid cyclopropanation is essential for viability, drug resistance, and cell wall integrity of Mycobacterium tuberculosis. Chem. Biol. 16:499-509.
3. Barry, C. E., III, R. E. Lee, K. Mdluli, A. E. Sampson, B. G. Schroeder, R. A. Slayden, and Y. Yuan. 1998. Mycolic acids: structure, biosynthesis and physiological functions. Prog. Lipid Res. 37:143-179.
4. Behr, M. A., B. G. Schroeder, J. N. Brinkman, R. A. Slayden, and C. E. Barry III. 2000. A point mutation in the mma3 gene is responsible for impaired methoxymycolic acid production in Mycobacterium bovis BCG strains obtained after 1927. J. Bacteriol. 182:3394-3399.
5. Bhatt, A., N. Fujiwara, K. Bhatt, S. S. Gurcha, L. Kremer, B. Chen, J. Chan, S. A. Porcelli, K. Kobayashi, G. S. Besra, and W. R. Jacobs, Jr. 2007. Deletion of kasB in Mycobacterium tuberculosis causes loss of acid-fastness and subclinical latent tuberculosis in immunocompetent mice. Proc. Natl. Acad. Sci. U. S. A. 104:5157-5162.
6. Camacho, L. R., D. Ensergueix, E. Perez, B. Gicquel, and C. Guilhot. 1999. Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis. Mol. Microbiol. 34:257-267.
7. Converse, S. E., J. D. Mougous, M. D. Leavell, J. A. Leary, C. R. Bertozzi, and J. S. Cox. 2003. MmpL8 is required for sulfolipid-1 biosynthesis and Mycobacterium tuberculosis virulence. Proc. Natl. Acad. Sci. U. S. A. 100:6121-6126.
8. Cox, J. S., B. Chen, M. McNeil, and W. R. Jacobs, Jr. 1999. Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice. Nature 402:79-83.
9. Dao, D. N., K. Sweeney, T. Hsu, S. S. Gurcha, I. P. Nascimento, D. Roshevsky, G. S. Besra, J. Chan, S. A. Porcelli, and W. R. Jacobs. 2008. Mycolic acid modification by the mmaA4 gene of M. tuberculosis modulates IL-12 production. PLoS Pathog. 4:e1000081.
10. Dubnau, E., J. Chan, C. Raynaud, V. P. Mohan, M. A. Laneelle, K. Yu, A. Quemard, I. Smith, and M. Daffe. 2000. Oxygenated mycolic acids are necessary for virulence of Mycobacterium tuberculosis in mice. Mol. Microbiol. 36:630-637.
11. Dubnau, E., H. Marrakchi, I. Smith, M. Daffe, and A. Quemard. 1998. Mutations in the cmaB gene are responsible for the absence of methoxymycolic acid in Mycobacterium bovis BCG Pasteur. Mol. Microbiol. 29:1526-1528.
12. George, K. M., Y. Yuan, D. R. Sherman, and C. E. Barry III. 1995. The biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis. Identification and functional analysis of CMAS-2. J. Biol. Chem. 270:27292-27298.
13. Glickman, M. S. 2003. The mmaA2 gene of Mycobacterium tuberculosis encodes the distal cyclopropane synthase of the alpha-mycolic acid. J. Biol. Chem. 278:7844-7849.
14. Glickman, M. S., S. M. Cahill, and W. R. Jacobs, Jr. 2001. The Mycobacterium tuberculosis cmaA2 gene encodes a mycolic acid trans-cyclopropane synthetase. J. Biol. Chem. 276:2228-2233.
15. Glickman, M. S., J. S. Cox, and W. R. Jacobs, Jr. 2000. A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis. Mol. Cell 5:717-727.
16. Grogan, D. W., and J. E. Cronan, Jr. 1984. Cloning and manipulation of the Escherichia coli cyclopropane fatty acid synthase gene: physiological aspects of enzyme overproduction. J. Bacteriol. 158:286-295.
17. Grogan, D. W., and J. E. Cronan, Jr. 1997. Cyclopropane ring formation in membrane lipids of bacteria. Microbiol. Mol. Biol. Rev. 61:429-441.
18. Guianvarc'h, D., T. Drujon, T. E. Leang, F. Courtois, and O. Ploux. 2006. Identification of new inhibitors of E. coli cyclopropane fatty acid synthase using a colorimetric assay. Biochim. Biophys. Acta 1764:1381-1388.
19. Guianvarc'h, D., E. Guangqi, T. Drujon, C. Rey, Q. Wang, and O. Ploux. 2008. Identification of inhibitors of the E. coli cyclopropane fatty acid synthase from the screening of a chemical library: in vitro and in vivo studies. Biochim. Biophys. Acta 1784:1652-1658.
20. MacGurn, J. A., and J. S. Cox. 2007. A genetic screen for Mycobacterium tuberculosis mutants defective for phagosome maturation arrest identifies components of the ESX-1 secretion system. Infect. Immun. 75:2668-2678.
21. Middlebrook, G., R. J. Dobos, and C. Pierce. 1947. Virulence and morphological characteristics of mammalian tubercle bacilli. J. Exp. Med. 86:175-184.
22. Raghunand, T. R., W. R. Bishai, and P. Chen. 2006. Towards establishing a method to screen for inhibitors of essential genes in mycobacteria: evaluation of the acetamidase promoter. Int. J. Antimicrob. Agents 28:36-41.
23. Rao, V., N. Fujiwara, S. A. Porcelli, and M. S. Glickman. 2005. Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule. J. Exp. Med. 201:535-543.
24. Rao, V., F. Gao, B. Chen, W. R. Jacobs, Jr., and M. S. Glickman. 2006. Trans-cyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis-induced inflammation and virulence. J. Clin. Invest. 116:1660-1667.
25. Vaubourgeix, J., F. Bardou, F. Boissier, S. Julien, P. Constant, O. Ploux, M. Daffe, A. Quemard, and L. Mourey. 2009. S-adenosyl-N-decyl-aminoethyl, a potent bisubstrate inhibitor of Mycobacterium tuberculosis mycolic acid methyltransferases. J. Biol. Chem. 284:19321-19330.
26. Yuan, Y., and C. E. Barry III. 1996. A common mechanism for the biosynthesis of methoxy and cyclopropyl mycolic acids in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U. S. A. 93:12828-12833.
27. Yuan, Y., D. C. Crane, J. M. Musser, S. Sreevatsan, and C. E. Barry III. 1997. MMAS-1, the branch point between cis- and trans-cyclopropane-containing oxygenated mycolates in Mycobacterium tuberculosis. J. Biol. Chem. 272:10041-10049.
28. Yuan, Y., R. E. Lee, G. S. Besra, J. T. Belisle, and C. E. Barry III. 1995. Identification of a gene involved in the biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U. S. A. 92:6630-6634.